当前位置:首页 - 行情中心 - 西藏药业(600211) - 财务分析 - 现金流量表

西藏药业

(600211)

  

流通市值:132.12亿  总市值:132.12亿
流通股本:3.22亿   总股本:3.22亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金2,488,285,507.951,631,403,149.1819,506,994.563,259,882,224.39
  收到的税费返还1,627,627.91,627,627.91,619,757.68-
  收到其他与经营活动有关的现金87,377,827.9461,907,845.2214,620,220.92272,434,359.39
  经营活动现金流入小计2,577,290,963.791,694,938,622.22835,746,973.163,532,316,583.78
  购买商品、接受劳务支付的现金202,955,243131,266,052.0978,061,223.59196,558,048.13
  支付给职工以及为职工支付的现金80,721,467.4259,814,316.5840,126,510.96103,655,981.08
  支付的各项税费306,210,871.98170,914,154.0378,043,536.58500,593,565.55
  支付其他与经营活动有关的现金1,274,338,468.49732,728,827.9329,705,756.461,736,718,177.2
  经营活动现金流出小计1,864,226,050.891,094,723,350.6525,937,027.592,537,525,771.96
  经营活动产生的现金流量净额713,064,912.9600,215,271.62309,809,945.57994,790,811.82
二、投资活动产生的现金流量:
  收回投资收到的现金3,152,991,516.22,290,217,266.661,050,000,0004,888,506,857.01
  取得投资收益收到的现金15,787,481.0711,544,178.196,215,668.2421,392,476.51
  处置固定资产、无形资产和其他长期资产收回的现金净额-215,734.17-2,783,258.1
  收到的其他与投资活动有关的现金161,633,808.81---
  投资活动现金流入小计3,330,412,806.082,301,977,179.021,056,215,668.244,912,682,591.62
  购建固定资产、无形资产和其他长期资产支付的现金10,974,808.099,346,117.474,801,433.2337,596,774.61
  投资支付的现金3,920,000,0002,690,924,116.431,350,000,0004,520,600,000
  投资活动现金流出小计3,930,974,808.092,700,270,233.91,354,801,433.234,558,196,774.61
  投资活动产生的现金流量净额-600,562,002.01-398,293,054.88-298,585,764.99354,485,817.01
三、筹资活动产生的现金流量:
  吸收投资收到的现金---1,450,000
  其中:子公司吸收少数股东投资收到的现金---1,450,000
  取得借款收到的现金816,728,712.81592,245,988.53243,970,643.18533,497,148.22
  收到其他与筹资活动有关的现金-4,014,383.62--
  筹资活动现金流入小计816,728,712.81596,260,372.15243,970,643.18534,947,148.22
  偿还债务支付的现金172,032,142.37172,074,396.49-760,967,884.95
  分配股利、利润或偿付利息支付的现金606,429,827.43321,496,317.1585,526,605.53506,033,063.48
  其中:子公司支付给少数股东的股利、利润1,212,2001,212,200-1,980,000
  支付其他与筹资活动有关的现金---938,971
  筹资活动现金流出小计778,461,969.8493,570,713.6485,526,605.531,267,939,919.43
  筹资活动产生的现金流量净额38,266,743.01102,689,658.51158,444,037.65-732,992,771.21
四、汇率变动对现金及现金等价物的影响-1,319,965.01-4,034,954.9-1,358,179.417,437,746.19
五、现金及现金等价物净增加额149,449,688.89300,576,920.35168,310,038.82623,721,603.81
  加:期初现金及现金等价物余额1,305,901,166.051,305,901,166.051,305,901,166.05682,179,562.24
  期末现金及现金等价物余额1,455,350,854.941,606,478,086.41,474,211,204.871,305,901,166.05
补充资料:
  净利润-570,788,875.89-1,057,075,195.66
  资产减值准备--1,390,321.15-436,114.52
  固定资产和投资性房地产折旧-22,593,264.24-48,516,377.82
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-22,593,264.24-48,516,377.82
  无形资产摊销-13,600,918.99-26,686,090.16
  长期待摊费用摊销-232,454.73-637,672.2
  处置固定资产、无形资产和其他长期资产的损失--152,695.47--1,960,495.62
  固定资产报废损失---65,077.18
  公允价值变动损失-821,339.67-18,985,201.5
  财务费用--596,985.54--18,251,694.09
  投资损失--4,537,623.79--15,103,560.39
  递延所得税-2,785,433.53--36,858,385.06
  其中:递延所得税资产减少-2,569,513.22--35,572,239.37
    递延所得税负债增加-215,920.31--1,286,145.69
  存货的减少--15,089,532.53--22,563,250.89
  经营性应收项目的减少--234,758,097.95-98,834,951.35
  经营性应付项目的增加-245,468,066.23--163,732,023.5
  其他---2,023,540.98
  现金的期末余额-1,606,478,086.4-1,305,901,166.05
  减:现金的期初余额-1,305,901,166.05-682,179,562.24
  现金及现金等价物的净增加额-300,576,920.35-623,721,603.81
公告日期2025-10-312025-08-162025-04-292025-03-15
审计意见(境内)标准无保留意见
TOP↑